David Waugh

Professor David Waugh is the Inaugural Pro-Vice Chancellor for Health and Medical Research and Engagement at University of South Australia, a role focused on developing inter-disciplinary and impactful research programmes that provide transformative solutions to inform improved patient outcomes and future healthcare practice. He was formerly the Head of School for Biomedical Sciences at Queensland University of Technology and prior to emigrating to Australia, he served as Director of the Patrick G Johnston Centre for Cancer Research at Queen’s University and the CRUK Belfast Cancer Centre, developing an ecosystem that integrated academic discovery science with entrepreneurial biotech research and development and finally implementation in innovative early-phase clinical trials. A Professor of Molecular Oncology and Therapeutics, David is an internationally-respected prostate cancer researcher focusing on using scientific discoveries to inform the use of new therapies in treating men with prostate cancer. He was the Founding Director of the FASTMAN Movember/PCUK Centre of Excellence (2013-2018) between Queen’s University Belfast and the University of Manchester in the UK, a programme delivering biomarkers and a series of translational studies to improve the outcomes of prostate cancer patients being treated for high-risk disease using radiotherapy protocols. His own research has focused on disrupting the inflammatory storms driven by chemokine signalling that underpin the aggressive and life-threatening behaviour of specific, genetically-defined subtypes of prostate cancer. Prostate cancer research, molecular oncology, therapeutics, chemokine signalling, inflammatory storms, biomarkers, translational studies, radiotherapy protocols

[2026] Le Magnen, C., Brennen, W. N., Aytes, Á., Bock, N., Bristow, R. G., Choo, N., . . . Lawrence, M. G. (2026). Patient-derived models of prostate cancer: Capturing tumour complexity from initiation to metastasis. Cancer Letters, 659, 17 pages. [2025] Hindes, M. T., McElligott, A. M., Best, O. G., Ward, M. P., Selemidis, S., Miles, M. A., . . . Brooks, D. A. (2025). Metabolic reprogramming, malignant transformation and metastasis: Lessons from chronic lymphocytic leukaemia and prostate cancer. Cancer Letters, 611(217441), 217441-1-217441-18. [2025] Grist, E., Dutey-Magni, P., Parry, M. A., Mendes, L., Sachdeva, A., Proudfoot, J. A., . . . Attard, G. (2025). Tumor transcriptome-wide expression classifiers predict treatment sensitivity in advanced prostate cancers.. Cell, 188(20), 1-29. [